Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023380 (lethargy)
 5,697 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

This double-blind, three-way crossover study measured the influence of beta-blocker treatment on drowsiness and mental test performance in older hypertensive patients and determined if lipophilicity was a determinant of these effects. Twenty-seven hypertensive patients (mean age, 63 +/- 3 years) were studied. Patients received two weeks each of daily treatment with placebo, 100 mg of atenolol, or 150 mg of metoprolol tartrate and were evaluated on the 14th day of each treatment period, after which their next treatment period began. Mental performance was measured using Trails-A maze testing. Drowsiness was measured subjectively using a visual analogue scale, and objectively using critical fusion-frequency threshold testing. Blood pressure control was equivalent and clinically adequate in all subjects. Steady-state levels of metoprolol tartrate (235.7 +/- 46 ng/mL) and atenolol (453.6 +/- 56 ng/nL) achieved were those expected to produce similar beta-blockade. Mental performance as measured by Trials-A testing showed better scores during beta-blocker treatment compared with placebo. Trails-A scores improved as patients went from placebo to metoprolol treatment, but did not change as patients went from placebo to atenolol treatment. Critical fusion-frequency threshold measurements were lower following administration of both drugs than following that of placebo, but subjectively there was no difference in feelings of lethargy between either beta-blocker and placebo. These data show greater improvement in mental testing performance to be associated with metoprolol treatment, but neither produced more lethargy than placebo in elderly patients.
 ...
PMID:The effect of beta-blockers on mental performance on older hypertensive patients. 271 20

A 7-year-old, intact male Dachshund was presented to the Lyon veterinary school for lethargy and anorexia of several weeks duration. The main clinical signs were pale and icteric mucous membranes, hepatomegaly, splenomegaly, and lymphadenopathy. Results of a CBC and plasma biochemistry tests revealed severe nonregenerative anemia, thrombocytopenia, and increased alanine aminotransferase and alkaline phosphatase activities. Blood smear evaluation and cytologic examination of lymph node and bone marrow aspirate specimens revealed a large population of poorly differentiated blast cells with morphologic features suggesting megakaryocytic lineage. A low number of well-differentiated but dysplastic megakaryocytes also were observed in lymph node and bone marrow smears. A few blast cells were erythrophagocytic. Blast cells were positive for glycoprotein IIIa, factor VIII-related antigen, and factor XIII using immunocytochemistry. The dog was euthanized and necropsied. Histologic findings consisted of diffuse, massive infiltration of lymph nodes, liver, and spleen by megakaryoblasts and atypical megakaryocytes, with widespread thrombosis. This case confirms the usefulness of immunochemistry, including for factor XIII, in the diagnosis of megakaryoblastic leukemia, and demonstrates the unique features of tumor cell erythrophagocytosis and marked fibrinous thrombosis, which have not been reported previously in dogs.
 ...
PMID:Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog. 1573 19

In 2005, the Olive Leaf Wholeness Center conducted a demonstration project that provided health assessment, testing, and treatment to 160 uniformed service personnel and residents of Lower Manhattan who were exposed to the air at Ground Zero following September 11, 2001, for extended periods of time. The program, known as Project Olive ReLeaf, found that most individuals had eight or more serious health complaints, including severe respiratory problems, digestive problems, skin rashes, sleeplessness, anxiety, depression, weight gains, elevated blood pressure, lethargy, and recurrent headaches. Heavy metal toxicity was suspected as a causal factor for many of these symptoms. Of those tested for heavy metal toxicity, using a challenge urine test, 85% had excessively high levels of lead and mercury. Chelation treatment using dimercaptuosuccinic acid (DMSA), a Food and Drug Administration (FDA)-approved sulfur compound, was the primary treatment prescribed. After three to four months of treatment, the first cohort of 100 individuals reported significant (greater than 60%) improvement in all symptoms. (This demonstration program was developed based on the results of an earlier pilot in 2003 for 25 emergency service officers of the New York City Police Department.) In addition, adjunctive therapies to assist with the detoxification process and build the immune system were offered. A small grant has been received to conduct follow-up tests on a sample of those treated with DMSA.
 ...
PMID:Findings of and treatment for high levels of mercury and lead toxicity in ground zero rescue and recovery workers and lower Manhattan residents. 1697 2